Selection of Cases to Review

At the heart of MetResect are 51 cases with expert commentary. There are 3 ways to access them: "By Category," "By Faculty," and "By Case Matching."

"By Category"

This splits the cases by 3 crucial categories into 5 groups. The most important question initially to be asked of colorectal disease metastatic to the liver at the time of its discovery is whether it is resectable. This question hinges on whether the metastatic disease is restricted to the liver, and whether it is initially resectable or might be converted to a resectable state. Another initial parameter that in a practical way often influences the therapeutic approach is whether the disease is discovered at the time of the discovery of the primary disease (is synchronous) or is discovered as recurrent metastatic disease at some later time in the clinical course (is metachronous). An additional category breaks them out by whether there was extrahepatic disease as some of these cases are considered possibly operable.

Using this page you can select cases by the general category and by the faculty who commented on them.

Cases were grouped in five general categories. Click Group Number to go to the grouped cases and further explore them.

• Group 1: Metachronous Arguably Resectable Liver-Only Disease at Presentation (Cases 1-12)
• Group 2: Metachronous Potentially Convertible Liver-Only Disease at Presentation (Cases 13-25)
• Group 3: Synchronous and Arguably Initially Resectable Liver Disease (Cases 26-34)
• Group 4: Synchronous and Potentially Convertible Liver Disease (Cases 35-44)
• Group 5: Liver Metastases with Simultaneous Extrahepatic Disease (Lung or Nodes) (Cases 45-51)

"By Faculty"

This allows you to review all the cases presented by a given faculty member.

• Rene Adam, MD
• Steven Alberts, MD
• Michael Choti, MD
• Steven Curley, MD
• Axel Grothey, MD
• Daniel Haller, MD
• Nicholas Petrelli, MD
• John Primrose, MD
• Alan Venook, MD

"By Case Matching"

Using the "Case Matching" tool you can enter information related to the tumor (whether the metastatic disease was unilobar or bilobar) and the timing of its presentation (whether synchronous or metachronous). You will also enter crucial information relating to resectability: whether the post-operative margins are expected to be negative, and whether post-operative hepatic reserve is expected to be adequate.

Copyright © 2008-2009 Research To Practice. All Rights Reserved.